Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K/A | 10-K/A | 10-K | S-1 |
| Revenues: |
| Other | 13.0 | 12.1 | | |
| Other | 114.6 | 111.3 | | |
| Revenues | 127.6 | 123.3 | 103.8 | 116.9 |
| Revenue growth [+] | 3.4% | 18.8% | -11.2% | |
| Other | 7.5% | | | |
| Cost of goods sold | 112.3 | 104.7 | 87.4 | 100.0 |
| Gross profit | 15.2 | 18.6 | 16.4 | 16.9 |
| Gross margin | 11.9% | 15.1% | 15.8% | 14.5% |
| Selling, general and administrative | 12.3 | 11.5 | 8.4 | 9.6 |
| Research and development | 1.9 | 2.1 | 2.0 | 1.9 |
| EBITDA [+] | 5.9 | 9.9 | 10.7 | 10.3 |
| EBITDA growth | -40.3% | -7.5% | 4.4% | |
| EBITDA margin | 4.7% | 8.1% | 10.3% | 8.8% |
| Depreciation | 2.3 | 2.3 | 2.2 | 2.2 |
| EBITA | 3.6 | 7.7 | 8.6 | 8.0 |
| EBITA margin | 2.8% | 6.2% | 8.2% | 6.9% |
| Amortization of intangibles | 2.5 | 2.5 | 2.5 | 2.5 |
| EBIT [+] | 1.1 | 5.1 | 6.0 | 5.5 |
| EBIT growth | -78.8% | -14.8% | 9.4% | |
| EBIT margin | 0.8% | 4.2% | 5.8% | 4.7% |
| Non-recurring items [+] | 30.6 | | | |
| Asset impairment | 30.6 | | | |
| Interest expense | 1.9 | 3.0 | 5.0 | 5.4 |
| Interest expense | 1.9 | 3.0 | 5.0 | 5.4 |
| Other income (expense), net [+] | 0.0 | -1.0 | -2.2 | 0.0 |
| Gain (loss) on sale of assets | | | 0.0 | |
| Gain (loss) on debt retirement | | -1.0 | -2.2 | |
| Other | 0.0 | 0.0 | | 0.0 |
| Pre-tax income | -31.4 | 1.1 | -1.2 | 0.1 |
| Income taxes | 0.7 | -0.6 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% |
| Net income | -32.1 | 1.7 | -1.2 | 0.1 |
| Net margin | -25.2% | 1.4% | -1.1% | 0.1% |
| |
| Basic EPS [+] | ($3.27) | $0.19 | ($0.15) | |
| Growth | -1845.6% | -227.7% | | |
| Diluted EPS [+] | ($3.27) | $0.19 | ($0.15) | |
| Growth | -1845.6% | -227.7% | | |
| |
| Shares outstanding (basic) [+] | 9.8 | 9.1 | 8.0 | |
| Growth | 7.7% | 14.1% | | |
| Shares outstanding (diluted) [+] | 9.8 | 9.1 | 8.0 | |
| Growth | 7.7% | 14.1% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|